14 Year Old Boy Dies of Acne Treatment, Why Wont They Name the Tablet He Took?
Question by It’s just me.: 14 year old boy dies of acne treatment, why wont they name the tablet he took?
I don’t know if you’ve heard of this, but it made me very untrustful of acne medication and now I’m worried
Why wont they name the drug he took? is this news just a lie?
Article… http://news.bbc.co.uk/2/hi/uk_news/wales/south_east/7697479.stm
Best answer:
Answer by bookish
Sadly, this boy had an allergy to the medication. It can happen. For example, many people have a dangerous allergy to penicillin, but that doesn’t mean nobody should take penicillin.
Know better? Leave your own answer in the comments!
Melanotan (one) “afamelanotide” NBC News report, November 1991 – Melanotan (one) “afamelanotide” discovery by researchers at the University of Arizona in Tucson as explained by NBC News’ Robert Bazell (with Tom Brokaw introduction) in a November 1991 News report. Melanotan (one) is now being developed in Australia as a photoprotective medicine to treat people who’s skin is negatively affected (more than normal) by exposure to UV light. Clinuvel (originally named “Epitan”) is the company that has been working to develop it since 1999. They are currently conducting clinical trials (under the drug name “afamelanotide”). The expected release of Melanotan one on the market as a treatment option for Erythropoietic Protoporphyria (EPP) sufferers is likely to be either 2009 or 2010. Journal of the American Medical Association article that this report was based upon: jama.ama-assn.org www.clinuvel.com en.wikipedia.org melanotan.org afamelanotide
Multiple Sclerosis (MS) specialty drug treatment cost projected to exceed …
Filed under: drug treatment news articles
While many with MS have seen improved quality of life as a result of drug therapy, unfortunately these MS specialty drug cost increases were not associated with MS medical costs declining. These study … Don't insult one another or the subjects of our …
Read more on Sacramento Bee
Which TKI Should Be Recommended as Initial Treatment for CML in Chronic …
Filed under: drug treatment news articles
The lessons learned from the specifically ”targeted” treatment of patients with chronic myeloid leukemia (CML) using imatinib(Drug information on imatinib) (Gleevec) are now being applied with sometimes dramatic success in a variety of other tumors in …
Read more on Cancer Network